Univerzita Karlova v Praze / Charles University in Prague

University / College


Location: Praha / Prague / Prag, Czech Republic (CZ) CZ

ISNI: 000000041937116X

ROR: https://ror.org/024d6js02

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

European expert consensus statement on therapeutic goals in Fabry disease (2018) Wanner C, Arad M, Baron R, Burlina A, Elliott PM, Feldt-Rasmussen U, Fomin VV, et al. Journal article The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: Case finding, screening and characteristics of eligible participants (2018) Marzetti E, Cesari M, Calvani R, Msihid J, Tosato M, Rodriguez-Manas L, Lattanzio F, et al. Journal article ESPEN guideline on clinical nutrition and hydration in geriatrics (2018) Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Goisser S, Hooper L, Kießwetter E, et al. Journal article Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients (2018) Suttorp M, Metzler M, Shimada H, Bansal D, Gunes AM, Kalwak K, Sedlacek P, et al. Journal article Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial (2018) Suttorp M, Schulze P, Glauche I, Goehring G, Von Neuhoff N, Metzler M, Sedlacek P, et al. Journal article Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide Autogel/depot 120mg in the CLARINET open-label extension (2018) Pavel ME, Cwikla J, Wolin E, Phan A, Raderer M, Sedlackova E, Cadiot G, et al. Conference contribution Final Progression-Free Survival Analyses for Lanreotide Autogel/Depot 120 mg in Metastatic Enteropancreatic Neuroendocrine Tumors: The CLARINET Extension Study (2018) Wolin EM, Pavel ME, Cwikla JB, Phan AT, Raderer M, Sedlackova E, Cadiot G, et al. Conference contribution PLASMA LEVELS OF HSP90 ARE INCREASED IN INTERSTITIAL LUNG DISEASE AND SKIN FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS (2018) Storkanova H, Oreska S, Spiritovic M, Hermankova B, Pavelka K, Vencovsky J, Distler J, et al. Conference contribution PLASMA LEVELS OF HSP90 ARE INCREASED IN PATIENTS WITH SYSTEMIC SCLEROSIS WITH MORE SEVERE ORGAN INVOLVEMENT (2018) Storkanova H, Oreska S, Spiritovic M, Pavelka K, Vencovsky J, Distler J, Senolt L, et al. Conference contribution Mammary Analog Secretory Carcinoma of the Nasal Cavity Characterization of 2 Cases and Their Distinction From Other Low-grade Sinonasal Adenocarcinomas (2018) Baneckova M, Agaimy A, Andreasen S, Vanecek T, Steiner P, Slouka D, Svoboda T, et al. Journal article